Segall Bryant & Hamill’s Xylem XYL Stock Holding History

Segall Bryant & Hamill’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,975	Closed	-$222K	–	715
2023 Q2	$222K	Buy	+1,975	New	+$209K	﹤0.01%	671

Other funds holding XYL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Segall Bryant & Hamill's XYL Position: Q3 2023 in Review

Segall Bryant & Hamill sold out of Xylem (XYL) in Q3 2023, closing a stake of 1,975 shares — an estimated $222K sold.

Segall Bryant & Hamill first reported a position in XYL in Q2 2023 and held it in 1 quarter. The position peaked at $222K in Q2 2023. 872 funds tracked by Wall St. Rank hold XYL as of Q3 2023.

Segall Bryant & Hamill reported no remaining Xylem position as of Q3 2023 after selling out during the quarter.
Segall Bryant & Hamill sold 1,975 Xylem shares in Q3 2023, an estimated $222K.
Segall Bryant & Hamill first reported a position in Xylem in Q2 2023 and held it in 1 quarter.
Segall Bryant & Hamill's Xylem position peaked at $222K in Q2 2023.
872 funds tracked by Wall St. Rank held Xylem as of Q3 2023.

Based on Segall Bryant & Hamill's 13F filing for Q3 2023, filed 9 Nov 2023.